Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05735080
Title Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (INX-315-01)
Acronym INX-315-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyclix Bio
Age Groups: senior | adult
Covered Countries USA | AUS

No variant requirements are available.